Background Pulmonary endarterectomy (PEA) has been the most effective therapy for
chronic thromboembolic pulmonary hypertension (CTEPH). However, there is a substantial …

Background Hemodynamic variables like right atrial pressure (RAP), cardiac index (CI),
stroke volume index (SVI) and mixed venous oxygen saturation (SvO2) predict survival in …

Background: Pulmonary arterial hypertension (PAH) may complicate both portal
hypertension (Po-PAH) and HIV infection (HIV-PAH). These two conditions, however …

This work has the objective to describe the improvement introduced in the 1D thermo-fluid
dynamic simulation code developed to simulate hydrogen-fueled Internal Combustion …

Objective To optimise treatment of patients with pulmonary arterial hypertension (PAH), the
2015 European Society of Cardiology/European Respiratory Society guidelines recommend …

Background Pulmonary arterial hypertension (PAH) represents a rare complication of both
portal hypertension (Po-PAH) and HIV infection (HIV-PAH). Due to overlapping risk factors …

Background Balloon pulmonary angioplasty (BPA) represents a therapeutic option for the
treatment of chronic thromboembolic pulmonary hypertension (CTEPH) in patients who are …

Background Pulmonary arterial hypertension (PAH) is a progressive disease characterized
by small pulmonary arteries remodeling that leads to increased pulmonary vascular …

Background despite therapeutic improvement, pulmonary arterial hypertension (PAH) is still
a chronic, incurable, high mortality disease. Several clinical, laboratory, hemodynamic and …

Background patients with pulmonary arterial hypertension (PAH) associated with corrected
congenital heart disease (CHD) have a worse prognosis than other 3 groups of patients with …